Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition


Por: Mikropoulos, C, Selkirk, CGH, Saya, S, Bancroft, E, Vertosick, E, Dadaev, T, Brendler, C, Page, E, Dias, A, Evans, DG, Rothwell, J, Maehle, L, Axcrona, K, Richardson, K, Eccles, D, Jensen, T, Osther, PJ, van Asperen, CJ, Vasen, H, Kiemeney, LA, Ringelberg, J, Cybulski, C, Wokolorczyk, D, Hart, R, Glover, W, Lam, J, Taylor, L, Salinas, M, Feliubadalo, L, Oldenburg, R, Cremers, R, Verhaegh, G, van Zelst-Stams, WA, Oosterwijk, JC, Cook, J, Rosario, DJ, Buys, SS, Conner, T, Domchek, S, Powers, J, Ausems, MGEM, Teixeira, MR, Maia, S, Izatt, L, Schmutzler, R, Rhiem, K, Foulkes, WD, Boshari, T, Davidson, R, Ruijs, M, Helderman-van den Enden, ATJM, Andrews, L, Walker, L, Snape, K, Henderson, A, Jobson, I, Lindeman, GJ, Liljegren, A, Harris, M, Adank, MA, Kirk, J, Taylor, A, Susman, R, Chen-Shtoyerman, R, Pachter, N, Spigelman, A, Side, L, Zgajnar, J, Mora, J, Brewer, C, Gadea, N, Brady, AF, Gallagher, D, van Os, T, Donaldson, A, Stefansdottir, V, Barwell, J, James, PA, Murphy, D, Friedman, E, Nicolai, N, Greenhalgh, L, Obeid, E, Murthy, V, Copakova, L, McGrath, J, Teo, SH, Strom, S, Kast, K, Leongamornlert, DA, Chamberlain, A, Pope, J, Newlin, AC, Aaronson, N, Ardern-Jones, A, Bangma, C, Castro, E, Dearnaley, D, Eyfjord, J, Falconer, A, Foster, CS, Gronberg, H, Hamdy, FC, Johannsson, O, Khoo, V, Lubinski, J, Grindedal, EM, McKinley, J, Shackleton, K, Mitra, AV, Moynihan, C, Rennert, G, Suri, M, Tricker, K, Moss, S, Kote-Jarai, Z, Vickers, A, Lilja, H, Helfand, BT, Eeles, RA, IMPACT Study Collaborators

Publicada: 23 ene 2018
Resumen:
Background: Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic predisposition to PrCa due to BRCA1/2 mutations. This analysis evaluates the utility of PSA and PSAV for identifying PrCa and high-grade disease in this cohort. Methods: PSAV was calculated using logistic regression to determine if PSA or PSAV predicted the result of prostate biopsy (PB) in men with elevated PSA values. Cox regression was used to determine whether PSA or PSAV predicted PSA elevation in men with low PSAs. Interaction terms were included in the models to determine whether BRCA status influenced the predictiveness of PSA or PSAV. Results: 1634 participants had >= 3 PSA readings of whom 174 underwent PB and 45 PrCas diagnosed. In men with PSA >3.0 ng ml(-1), PSAV was not significantly associated with presence of cancer or high-grade disease. PSAV did not add to PSA for predicting time to an elevated PSA. When comparing BRCA1/2 carriers to non-carriers, we found a significant interaction between BRCA status and last PSA before biopsy (P = 0.031) and BRCA2 status and PSAV (P = 0.024). However, PSAV was not predictive of biopsy outcome in BRCA2 carriers. Conclusions: PSA is more strongly predictive of PrCa in BRCA carriers than non-carriers. We did not find evidence that PSAV aids decision-making for BRCA carriers over absolute PSA value alone.

Filiaciones:
Mikropoulos, C:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Selkirk, CGH:
 North Shore Univ Hlth Syst, Dept Surg, John & Carol Walter Ctr Urol Hlth, Evanston, IL 60201 USA

 North Shore Univ Hlth Syst, Dept Med, Ctr Med Genet, Evanston, IL 60201 USA

Saya, S:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Bancroft, E:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

 Royal Marsden NHS Fdn Trust, Fulham Rd, London SW3 6JJ, England

Vertosick, E:
 Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA

Dadaev, T:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Brendler, C:
 North Shore Univ Hlth Syst, Dept Surg, John & Carol Walter Ctr Urol Hlth, Evanston, IL 60201 USA

Page, E:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Dias, A:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

 Royal Marsden NHS Fdn Trust, Fulham Rd, London SW3 6JJ, England

Evans, DG:
 Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Div Evolut & Genom Sci, Gen Med Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England

Rothwell, J:
 Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Div Evolut & Genom Sci, Gen Med Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England

Maehle, L:
 Oslo Univ Hosp, Dept Med Genet, N-0372 Oslo, Norway

Axcrona, K:
 Akershus Univ Hosp, N-1478 Lorenskog, Norway

Richardson, K:
 Parkville Familial Canc Ctr, Peter MacCallum Canc Ctr, East Melbourne, Vic 3000, Australia

 Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia

Eccles, D:
 Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England

 Univ Southampton, Univ Hosp Southampton NHS Fdn Trust, Cancer Sci Fac Med, Southampton SO16 6YD, Hants, England

Jensen, T:
 Vejle Hosp, Dept Clin Genet, DK-7100 Vejle, Denmark

Osther, PJ:
 Vejle Hosp, Dept Clin Genet, DK-7100 Vejle, Denmark

van Asperen, CJ:
 Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands

Vasen, H:
 Netherlands Fdn Detect Hereditary Tumors, NL-2333 Nijmegen, GA, Netherlands

Kiemeney, LA:
 Radboud Univ Nijmegen, Med Ctr, NL-6525 Nijmegen, GA, Netherlands

Ringelberg, J:
 Netherlands Fdn Detect Hereditary Tumors, NL-2333 Nijmegen, GA, Netherlands

Cybulski, C:
 Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, PL-70204 Szczecin, Poland

Wokolorczyk, D:
 Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, PL-70204 Szczecin, Poland

Hart, R:
 Birmingham Womens Hosp, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England

Glover, W:
 Birmingham Womens Hosp, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England

Lam, J:
 Repatriat Gen Hosp, Dept Urol, Daw Pk, SA 5041, Australia

Taylor, L:
 Repatriat Gen Hosp, Dept Urol, Daw Pk, SA 5041, Australia

Salinas, M:
 Hosp Llobregat, Catalan Inst Oncol, ICO IDIBELL, CIBERONC,Hereditary Canc Program, Barcelona 08908, Spain

Feliubadalo, L:
 Hosp Llobregat, Catalan Inst Oncol, ICO IDIBELL, CIBERONC,Hereditary Canc Program, Barcelona 08908, Spain

Oldenburg, R:
 Erasmus MC, Dept Clin Genet, NL-3015 Rotterdam, Netherlands

Cremers, R:
 Radboud Univ Nijmegen, Med Ctr, NL-6525 Nijmegen, GA, Netherlands

Verhaegh, G:
 Radboud Univ Nijmegen, Med Ctr, NL-6525 Nijmegen, GA, Netherlands

van Zelst-Stams, WA:
 Netherlands Fdn Detect Hereditary Tumors, NL-2333 Nijmegen, GA, Netherlands

Oosterwijk, JC:
 Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 Groningen, Netherlands

Cook, J:
 Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield S10 2TH, S Yorkshire, England

Rosario, DJ:
 Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England

Buys, SS:
 Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USA

Conner, T:
 Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USA

Domchek, S:
 Univ Penn, Basser Res Ctr, Philadelphia, PA 19104 USA

Powers, J:
 Univ Penn, Basser Res Ctr, Philadelphia, PA 19104 USA

Ausems, MGEM:
 Univ Med Ctr Utrecht, Dept Genet, Utrecht, CX, Netherlands

Teixeira, MR:
 Portuguese Oncol Inst, Genet Dept, P-4200072 Oporto, Portugal

 Portuguese Oncol Inst, Res Ctr, P-4200072 Oporto, Portugal

 Univ Porto, Biomed Sci Inst ICBAS, P-4200072 Oporto, Portugal

Maia, S:
 Portuguese Oncol Inst, Genet Dept, P-4200072 Oporto, Portugal

 Portuguese Oncol Inst, Res Ctr, P-4200072 Oporto, Portugal

Izatt, L:
 Guys Hosp, South East Thames Genet Serv, London SE1 9RT, England

Schmutzler, R:
 Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, D-50829 Cologne, Germany

Rhiem, K:
 Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, D-50829 Cologne, Germany

Foulkes, WD:
 McGill Univ, Dept Oncol, McGill Program Canc Genet, Montreal, PQ, Canada

 McGill Univ, Dept Human Genet, Montreal, PQ, Canada

Boshari, T:
 McGill Univ, Dept Oncol, McGill Program Canc Genet, Montreal, PQ, Canada

 McGill Univ, Dept Human Genet, Montreal, PQ, Canada

Davidson, R:
 Duncan Guthrie Inst Med Genet, Yorkhill NHS Trust, Glasgow G38SJ, Lanark, Scotland

Ruijs, M:
 Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Helderman-van den Enden, ATJM:
 Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 HX Maastricht, Netherlands

Andrews, L:
 Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia

Walker, L:
 Churchill Hosp, Oxford OX3 7LE, England

Snape, K:
 St George Hosp, London SW17 0QT, England

Henderson, A:
 Newcastle Upon Tyne Hosp, Northern Genet Serv, Newcastle NE1 3BZ, England

Jobson, I:
 Newcastle Upon Tyne Hosp, Northern Genet Serv, Newcastle NE1 3BZ, England

Lindeman, GJ:
 Royal Melbourne Hosp, Parkville Familial Canc Ctr, Grattan St, Parkville, Vic 3050, Australia

 Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3050, Australia

 Univ Melbourne, Dept Med, Parkville, Vic 3050, Australia

Liljegren, A:
 Karolinska Univ Hosp, S-17184 Solna, Sweden

 Karolinska Inst, S-17184 Solna, Sweden

Harris, M:
 Monash Hlth, Familial Canc Ctr, Clayton, Vic 3168, Australia

Adank, MA:
 Vrije Univ Amsterdam Med Ctr, NL-1081 HV Amsterdam, Netherlands

Kirk, J:
 Westmead Hosp, Familial Canc Serv, Sydney, NSW 2145, Australia

 Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW 2155, Australia

Taylor, A:
 Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England

Susman, R:
 Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Herston, Qld 4029, Australia

Chen-Shtoyerman, R:
 Kaplan Med Ctr, Genet Inst, IL-76100 Rehovot, Israel

Pachter, N:
 King Edward Mem Hosp, Genet Serv WA, Subiaco, WA 6008, Australia

 Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia

Spigelman, A:
 Hunter Family Canc Serv, Waratah, NSW 2298, Australia

 Univ New South Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia

 St Vincents Hosp, Kinghorn Canc Ctr, Sydney, NSW 2010, Australia

Side, L:
 Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 3JH, England

 UCL Inst Womens Hlth, London WC1N 3JH, England

Zgajnar, J:
 Inst Oncol, Ljubljana 1000, Slovenia

Mora, J:
 Hosp Santa Creu & Sant Pau, Barcelona 08041, Spain

Brewer, C:
 Derriford Hosp, Peninsular Genet, Plymouth PL6 8DH, Devon, England

 Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England

Gadea, N:
 Vall dHebron Univ Hosp, High Risk & Canc Prevent Clin, Barcelona 08035, Spain

Brady, AF:
 London North West Healthcare NHS Trust, North West Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England

Gallagher, D:
 St James Hosp, Dublin 8, Ireland

van Os, T:
 Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

Donaldson, A:
 St Michaels Hosp, Bristol BS2 8EG, Avon, England

Stefansdottir, V:
 Landspitali Natl Univ Hosp Iceland, IS-101 Reykjavik, Iceland

Barwell, J:
 Univ Leicester, Leicester LE1 7RH, Leics, England

 Univ Hosp Leicester, Leicester LE1 5WW, Leics, England

James, PA:
 Parkville Familial Canc Ctr, Peter MacCallum Canc Ctr, East Melbourne, Vic 3000, Australia

 Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia

 Royal Melbourne Hosp, Genet Med, Melbourne, Vic 3050, Australia

Murphy, D:
 Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia

Friedman, E:
 Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel

 Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel

Nicolai, N:
 Ist Nazl Tumori, I-20133 Milan, Italy

Greenhalgh, L:
 Liverpool Womens Hosp, Cheshire & Mersey Clin Genet Serv, Liverpool L8 7SS, Merseyside, England

Obeid, E:
 Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

Murthy, V:
 Tata Mem Hosp, Mumbai 400012, Maharashtra, India

Copakova, L:
 Natl Canc Inst, Bratislava 83310, Slovakia

McGrath, J:
 Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England

Teo, SH:
 Subang Jaya Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Selangor 47500, Malaysia

Strom, S:
 Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

Kast, K:
 Tech Univ Dresden, Dept Gynecol & Obstet, Fac Med, D-01069 Dresden, Germany

 Tech Univ Dresden, Univ Hosp Carl Gustav Carus, D-01069 Dresden, Germany

 Natl Ctr Tumor Dis NCT, Partner Site Dresden, D-01307 Dresden, Germany

Leongamornlert, DA:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Chamberlain, A:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Pope, J:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Newlin, AC:
 North Shore Univ Hlth Syst, Dept Med, Ctr Med Genet, Evanston, IL 60201 USA

Aaronson, N:
 Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Ardern-Jones, A:
 Royal Marsden NHS Fdn Trust, Fulham Rd, London SW3 6JJ, England

Bangma, C:
 Erasmus MC, Dept Clin Genet, NL-3015 Rotterdam, Netherlands

Castro, E:
 Spanish Natl Canc Res Ctr, Prostate Canc Unit, Madrid 28029, Spain

Dearnaley, D:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

 Royal Marsden NHS Fdn Trust, Fulham Rd, London SW3 6JJ, England

Eyfjord, J:
 Univ Iceland, Sch Hlth Sci, Fac Med, IS-101 Reykjavik, Iceland

Falconer, A:
 Imperial Coll Healthcare NHS Trust, London W2 1NY, England

Foster, CS:
 HCA Healthcare Labs, London WC1E 6JA, England

Gronberg, H:
 Univ Hosp, S-90737 Umea, Sweden

Hamdy, FC:
 Churchill Hosp, Oxford OX3 7LE, England

 Univ Oxford, Nuffield Dept Surg Sci, Oxford OX1 2JD, England

Johannsson, O:
 Landspitali Natl Univ Hosp Iceland, IS-101 Reykjavik, Iceland

Khoo, V:
 Royal Marsden NHS Fdn Trust, Fulham Rd, London SW3 6JJ, England

Lubinski, J:
 Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, PL-70204 Szczecin, Poland

Grindedal, EM:
 Oslo Univ Hosp, Dept Med Genet, N-0372 Oslo, Norway

McKinley, J:
 Parkville Familial Canc Ctr, Peter MacCallum Canc Ctr, East Melbourne, Vic 3000, Australia

Shackleton, K:
 Royal Melbourne Hosp, Parkville Familial Canc Ctr, Grattan St, Parkville, Vic 3050, Australia

Mitra, AV:
 Univ Coll London Hosp NHS Fdn Trust, London NW1 2BU, England

Moynihan, C:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Rennert, G:
 CHS Natl Canc Control Ctr, Carmel Med Ctr, IL-31999 Haifa, Israel

Suri, M:
 City Hosp Nottingham, Nottingham NG5 1PB, England

Tricker, K:
 Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Div Evolut & Genom Sci, Gen Med Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England

Moss, S:
 Queen Mary Univ London, Ctr Canc Prevent, London EC1M 6BQ, England

Kote-Jarai, Z:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

Vickers, A:
 City Hosp Nottingham, Nottingham NG5 1PB, England

Lilja, H:
 Univ Oxford, Nuffield Dept Surg Sci, Oxford OX1 2JD, England

 Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10065 USA

 Mem Sloan Kettering Canc Ctr, Dept Surg & Med, New York, NY 10065 USA

Helfand, BT:
 North Shore Univ Hlth Syst, Dept Surg, John & Carol Walter Ctr Urol Hlth, Evanston, IL 60201 USA

Eeles, RA:
 Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

 Royal Marsden NHS Fdn Trust, Fulham Rd, London SW3 6JJ, England

Dresden & German Canc Res Ctr DKFZ, German Canc Consortium DKTK, D-69120 Heidelberg, Germany.
Lund Univ, Dept Translat Med, S-20502 Malmo, Sweden.
ISSN: 00070920





BRITISH JOURNAL OF CANCER
Editorial
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 118 Número: 2
Páginas: 266-276
WOS Id: 000423184900018
ID de PubMed: 29301143
imagen Hybrid Gold, Green Published, Green Accepted

MÉTRICAS